Date sent:      	Fri, 19 Jul 2002 

Rational and targeted pharmacologic treatment of fibromyalgia.

Rheum Dis Clin North Am 2002 May;28(2):261-90

Barkhuizen A.

Department of Medicine, Oregon Health and Science University, Portland VA
Medical Center, Portland, OR, USA. mailto:barkhuiz@ohsu.edu

PMID: 12122917


Despite disappointing results when subjected to randomized clinical trials,
pharmacologic agents remain an important component of FM management.

Addressing the main symptoms of pain, disturbed sleep, mood disturbances,
fatigue, and associated conditions is essential to improve patient
functioning and enhanced quality of life.

However, much work remains to design clinical trials which address the
complexity of FM, while satisfying evidence based medicine paradigms.